Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | P4HA1 | P13674 | 3/20 | 0.59 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.59 |
| ▸ | MIF | P14174 | 1/20 | 0.57 |
| ▸ | GABRP | O00591 | 1/20 | 0.55 |
| ▸ | GABRD | O14764 | 1/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.55 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.55 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.55 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.55 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.55 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.55 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.55 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.55 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29693605 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL11505192 | 0.98 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| Ammonia Solution, Strong SCHEMBL11504738 | 0.98 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| Hydrogen Sulfide SCHEMBL22616567 | 0.98 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| Ammonia Solution, Strong SCHEMBL11504736 | 0.98 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL11504397 | 0.98 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL11504865 | 0.98 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL11504782 | 0.98 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL22616569 | 0.96 | ALDH1A1 (0.92) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL13539393 | 0.88 | ALDH1A1 (0.79) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12419551-B2 | Mediation of in vivo analyte signal degradation | SENSEONICS, INCORPORATED (US) | 2025-09-23 | — | — | US | claimed |
| WO-2025074986-A1 | MODIFIED POLYCARBONATE, METHOD FOR PRODUCING MODIFIED POLYCARBONATE, AND RESIN COMPOSITION | 株式会社カネカ | 2025-04-10 | — | — | WO | claimed |
| EP-3965657-B1 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | SENSEONICS INC (US) | 2025-03-05 | — | — | EP | claimed |
| EP-4493743-A1 | GOLD ELECTROPLATING SOLUTION AND ITS USE FOR ELECTRODEPOSITING GOLD WITH AN AGED APPEARANCE | Université de Franche-Comté (FR) | 2025-01-22 | — | — | EP | claimed |
| US-20240132955-A1 | BENIGN SCAR-FORMING CLEAVABLE LINKERS | ULTIMA GENOMICS, INC. | 2024-04-25 | — | — | US | claimed |
| EP-4314324-A1 | BENIGN SCAR-FORMING CLEAVABLE LINKERS | Ultima Genomics, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| WO-2023174871-A1 | GOLD ELECTROPLATING SOLUTION AND ITS USE FOR ELECTRODEPOSITING GOLD WITH AN AGED APPEARANCE | Université de Franche-Comté (FR) | 2023-09-21 | — | — | WO | claimed |
| CN-116103922-B | Sweat-absorbing breathable elastic jean and preparation process thereof | 江苏德利恒棉业有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-116103922-A | Sweat-absorbing breathable elastic jean and preparation process thereof | 江苏德利恒棉业有限公司 | 2023-05-12 | — | — | CN | claimed |
| WO-2022212408-A1 | BENIGN SCAR-FORMING CLEAVABLE LINKERS | ULTIMA GENOMICS, INC. (US) | 2022-10-06 | — | — | WO | claimed |
| EP-0782632-A1 | A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of Health and Human Services (US) | 1997-07-09 | — | — | EP | claimed |
| WO-1996009406-A9 | A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN | — | 1996-05-23 | — | — | WO | claimed |
| WO-1996009406-A1 | A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-03-28 | — | — | WO | claimed |
| EP-0527186-A4 | — | UNIV ILLINOIS (US) | 1995-01-18 | — | — | EP | claimed |
| EP-0527186-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | The Board of Trustees for the University of Illinois (US) | 1993-02-17 | — | — | EP | claimed |
| EP-0464388-A1 | Detection assays having chromogenic and nonchromogenic, hypocromogenic, bathochromogenic or hypsochromogenic substrates | TECHNICON INSTRUMENTS CORPORATION (a New York corporation) (US) | 1992-01-08 | — | — | EP | claimed |
| WO-1991016820-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1991-11-14 | — | — | WO | claimed |
| US-4378364-A | DITHIOBIS(PYRIDINE-CARBOXYLIC ACID) TO RELIEVE PAIN, INCREASE APPETITE | GRASSETTI DAVIDE R | 1983-03-29 | — | — | US | claimed |
| US-4152439-A | 6,6-DITHIODINICOTINIC ACID, ESTER OR ALKALI METAL OR AMMONIUM SALT | Grassetti, Davide R. (US) | 1979-05-01 | — | — | US | claimed |
| US-4036709-A | ORGANIC DISULFIDE | M & T CHEMICALS INC. (US) | 1977-07-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12419551-B2 | Mediation of in vivo analyte signal degradation | SLC2A1, TXN2, SLC2A8 | ALDH1A1 323/4885CYP1A2 2625/4885CYP2C9 1518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.